Literature DB >> 11105058

Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocysts.

E Kawase1, Y Yamazaki, T Yagi, R Yanagimachi, R A Pedersen.   

Abstract

We have established mouse embryonic stem (ES) cell lines from blastocysts derived by transfer of nuclei of fetal neuronal cells. These neuronal cell-derived embryonic cell lines had properties that characterize them as ES cells, including typical cell markers and alkaline phosphatase activity. Moreover, the cells had a normal karyotype and were pluripotent, as they were capable of differentiating into all three germ layers. Although they were derived from neuronal donor nuclei, the cells no longer expressed neuronal markers; however, they were capable of differentiating into cells with neuronal characteristics. These results suggest that the clone-derived cells have fully acquired an ES cell character. Thus, ES cells can be derived from embryos resulting from nuclear transfer, which results in reprogramming of the genetic information and acquisition of pluripotency. ES cells established from somatic cell-derived blastocysts could be useful not only as research tools for studying reprogramming but also as models for cell-based transplantation therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105058

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  21 in total

1.  Assessment of the developmental totipotency of neural cells in the cerebral cortex of mouse embryo by nuclear transfer.

Authors:  Y Yamazaki; H Makino; K Hamaguchi-Hamada; S Hamada; H Sugino; E Kawase; T Miyata; M Ogawa; R Yanagimachi; T Yagi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Propagation of an infertile hermaphrodite mouse lacking germ cells by using nuclear transfer and embryonic stem cell technology.

Authors:  Sayaka Wakayama; Satoshi Kishigami; Nguyen Van Thuan; Hiroshi Ohta; Takafusa Hikichi; Eiji Mizutani; Ryuzo Yanagimachi; Teruhiko Wakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

Review 3.  Therapeutic cloning in the mouse.

Authors:  Peter Mombaerts
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-29       Impact factor: 11.205

4.  Equivalency of buffalo (Bubalus bubalis) embryonic stem cells derived from fertilized, parthenogenetic, and hand-made cloned embryos.

Authors:  Musharifa Muzaffar; Naresh L Selokar; Karn P Singh; Mohammad Zandi; Manoj K Singh; Riaz A Shah; Manmohan S Chauhan; Suresh K Singla; Prabhat Palta; Radheysham Manik
Journal:  Cell Reprogram       Date:  2012-05-14       Impact factor: 1.987

Review 5.  Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome.

Authors:  Danièle Pralong; Alan O Trounson; Paul J Verma
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 6.  Cloned mice and embryonic stem cell establishment from adult somatic cells.

Authors:  Satoshi Kishigami; Sayaka Wakayama; N van Thuan; Teruhiko Wakayama
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

7.  Comparative analysis of nuclear transfer embryo-derived mouse embryonic stem cells. Part I: cellular characterization.

Authors:  Julianna Kobolak; Solomon Mamo; Ruttachuk Rungsiwiwut; Olga Ujhelly; Erika Csonka; Gyula Hadlaczky; Andras Dinnyes
Journal:  Cell Reprogram       Date:  2011-12-28       Impact factor: 1.987

Review 8.  Cloned human embryonic stem cells for tissue repair and transplantation.

Authors:  Woo Suk Hwang; Byeong Chun Lee; Chang Kyu Lee; Sung Keun Kang
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 9.  Stem cells in the treatment of cardiovascular disease--an overview.

Authors:  Amita J Hotkar; Warren Balinsky
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

Review 10.  The role of stem cells for treatment of cardiovascular disease.

Authors:  M J Lovell; A Mathur
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.